Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

Bio-Rad buys Ciphergen's life science instrument business

17-Aug-2006 - Ciphergen Biosystems has agreed to sell its proteomics instrument business to life science research firm Bio-Rad Laboratories for $20m (€15.6m).

New automated cell counting tool to save labs time

17-Aug-2006 - Nexcelom Bioscience, a provider of instruments for cell-based assays, has just launched a new cell counter to make the cell counting process quicker and easier.

Merck 'delayed or impeded' probe into release from production plant

16-Aug-2006 - Pennsylvania environmental regulators have accused Merck of hampering their investigation of a chemical discharge from its West Point facility that resulted in a major fish kill on the local creek and threatened the water supplies for the city of Philadelphia.

Embrex helps Chinese vaccine producer not to lay an egg

15-Aug-2006 - Agricultural firm Embrex has installed its in ovo delivery system and egg remover at the production facility of Shenzhen Neptunus Interlong, believed to be the largest and most advanced human influenza vaccine manufacturing plant in China.

New light microscope to pinpoint single proteins

15-Aug-2006 - Researchers have developed a new light microscope that is so powerful ituses a nanometre-scale resolution to spot individual proteins in a cell byusing a fluorescent labelling method.

Manufacturing double whammy to cost Patheon millions

15-Aug-2006 - More problems at Patheon's Puerto Rican production facilities in the third quarter of 2006 are expected to reduce the contract manufacturer's earnings before interest, tax, depreciation and amortisation (EBITDA) by more than $9m (€7m) compared to last year, forcing it to negotiate its credit agreement with its lenders.

FDA cracks down on the unauthorised production of inhalation drugs

14-Aug-2006 - The US Food and Drug Administration (FDA) has censured three American national pharmacies for using the traditional practice of compounding as a ruse in order to operate as drug manufacturers, producing thousands of unapproved copies of commercially available nebuliser medications that do not meet good manufacturing practice (GMP) standards.

Genzyme given green light to make kidney drug at Irish plant

14-Aug-2006 - US biotech firm Genzyme has been given a green light by the US Food and Drug Administration (FDA) to begin manufacturing its kidney drug at its Waterford facility in Ireland.

Infra-Red analyser awarded best product

10-Aug-2006 - An Infra-Red analyser has been named one of the Top 100 most technologically significant products introduced into the marketplace over the past year.

Seeing through formulation problems

10-Aug-2006 - Drug manufacturers are increasingly turning to specialised providers of analytical services for the solid state characterisation of their formulations, seeking answers to processing issues, drug delivery challenges and even protecting drug patents.

New test to identify patients at low blood clot risk

10-Aug-2006 - Researchers have found that a simple and inexpensive test can help determine which patients with venous thromboembolism (VTE) are at low risk for recurrence and can therefore avoid unnecessary and potentially dangerous long-term anticoagulant treatment.

Campbell Brothers targets Scandinavian market

10-Aug-2006 - Australian-owned Campbell Brothers has entered the Scandinavian laboratory market by acquiring Swedish-based lab group Analytica.

Pharma industry to drive activated carbon growth

09-Aug-2006 - The global demand for virgin activated carbon is tipped to rise five per cent per year to reach 1.2m metric tons by 2010, fuelled by increased use in the pharmaceutical sector.

Optical discovery opens way to lab-on-a-chip technology

08-Aug-2006 - Researchers have created a compact optical device that could make"lab-on-a-chip" possible by shrinking all the sensing power of biosensorsand developing a new design for photonic crystals in the process.

New two-fluid nozzle for inhaled drug production

08-Aug-2006 - Niro Pharma Systems has launched a new spray-drying nozzle to produce commercial quantities of fine powder drugs for inhalation.

Steritool launches cleanroom-friendly crowbar

07-Aug-2006 - Steritool has launched the world's first crowbar made entirely of stainless steel - designed to serve in zero-particulate environments and eliminate contamination.

Scaling up for commercialisation

07-Aug-2006 - Failure to get it right in designing and implementing a manufacturing process results in the loss of time and money, but the risk of this can be minimised if some basic organisational steps are followed, argues Brookwood's director of manufacturing.

New method to "glue" cells on carriers

03-Aug-2006 - Researchers have developed a new method by which cells can be glued to an exact position on a carrier.

Cambrex yet to stem Biopharma bleed

03-Aug-2006 - Cambrex's Q2 results show that the life sciences firm is slowly making a comeback after being crushed by a $140.3m (€116.7m) loss in Q4, however, it has failed to completely stem the bleed from its Biopharma unit, blamed for much of the company's woes.

Canadian lab named reference centre for BSE

03-Aug-2006 - Canada's National Centre for Foreign Animal Disease (NCFAD) has been designated as a reference lab for Bovine Spongiform Encephalopathy (BSE) by the World Organisation for Animal Health known as the OIE.

Nektar abandons UK operations

02-Aug-2006 - Nektar Therapeutics has closed its processing plant in Bradford, UK as it shifts its focus to developing its own drug products using its own drug delivery technology.

PerkinElmer acquisitions expands maternal diagnostics arm

01-Aug-2006 - PerkinElmer has announced the acquisition of Macri Technologies and NTL Laboratories in a deal that means the Health Sciences and Photonics company take charge of a novel screening test for first-trimester prenatal risk assessment.

Overcoming bottlenecks in the manufacturing of biologics

01-Aug-2006 - Most pharmaceutical companies know little about how to make biopharmaceuticals on a large scale and so they need to develop in-house expertise as well as outsource several steps in their production chain, advises the head of chemistry and production at Genzyme Pharmaceuticals.

New paper demonstrates power of laboratory mass spectrometers

27-Jul-2006 - Mass spectroscopy as an analytical laboratory technique proved it's worth again recently after Cerno Bioscience and Wyeth Pharmaceuticals jointly produced a paper that demonstrates the high mass accuracy that can be achieved using triple quadrupole mass spectrometers.

Omnia Biologics seals TB vaccine production deal

26-Jul-2006 - Omnia Biologics has sealed a deal to help the Aeras Global TB Vaccine Foundation in its quest to make quantities of a new TB Vaccine that will "fulfil all the needs of the developing world."

Sign up for your free newsletter

Supplier Webinars